Australia markets open in 6 hours 3 minutes

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
53.23+0.09 (+0.17%)
As of 12:57PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts13131413
Avg. Estimate-0.91-0.93-3.7-3.89
Low estimate-1.03-1.07-3.91-4.51
High estimate-0.74-0.79-3.39-2.85
Year ago EPS-1.01-0.9-3.69-3.7
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts10101112
Avg. Estimate240k740k1.99M11.85M
Low estimateN/AN/A1M3M
High estimate1M5M6M57M
Year ago sales120kN/A4.01M1.99M
Sales growth (year/est)100.00%N/A-50.40%495.50%
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.86-0.86-0.81-0.86
Actual EPS-1.01-0.9-0.93-0.94
Difference-0.15-0.04-0.12-0.08
Surprise %-17.40%-4.70%-14.80%-9.30%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.91-0.93-3.7-3.89
7 days ago-0.91-0.93-3.7-3.89
30 days ago-0.91-0.93-3.7-3.89
60 days ago-0.91-0.93-3.7-3.89
90 days ago-0.88-0.9-3.57-3.81
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCRNXIndustrySector(s)S&P 500
Current qtr.9.90%N/AN/AN/A
Next qtr.-3.30%N/AN/AN/A
Current year-0.30%N/AN/AN/A
Next year-5.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A